FH2-17138-67707
2 vaccinations
9 coded responses
23 check-ins
9 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 386 / MS
- Registered
- 2021-03-05
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-05
Registered in v-safe
-
2021-03-05
Dose 1 — Pfizer-BioNTech
-
2021-03-05
Survey response — day 0, dose 1MedDRA: No adverse event — Feeling: Good · Site: Pain · Fatigue or tirednessFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-06
Survey response — days 1–6 daily, dose 1MedDRA: No adverse event — Feeling: Good · Site: PainFree text: NoneMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-07
Survey response — days 1–6 daily, dose 1MedDRA: No adverse event — Feeling: Good · Site: PainFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-08
Survey response — days 1–6 daily, dose 1MedDRA: No adverse event — Feeling: GoodFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-09
Survey response — days 1–6 daily, dose 1MedDRA: No adverse event — Feeling: GoodFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-10
- 2021-03-11
- 2021-03-12
-
2021-03-19
Survey response — day 14, dose 1MedDRA: Dyspnoea, Sluggishness — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Having some shortness of breath that may be related to allergies. Daily activities are about the same; may be a little sluggish from the OTC medication.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-26
Dose 2 — Pfizer-BioNTech
-
2021-03-27
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
- 2021-03-28
- 2021-03-29
- 2021-03-30
- 2021-04-01
- 2021-04-02
- 2021-04-09
-
2021-04-16
Survey response — day 21, dose 2MedDRA: Skin irritation, Urticaria — Feeling: GoodFree text: Yes, Ive had welts on my neck and back this week and the previous week. They are not bothersome unless I wear clothing that rubs the areas. Ill keep watch on these areas to determine if I will seek medical attention.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-23
- 2021-04-30
- 2021-05-07
-
2021-06-25
Survey response — 3 months, dose 2MedDRA: Gout, Office visit — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Ive suddenly developed gout in my foot. I have no family history and eat a fairly balanced diet. · Healthcare visit (other): Office visitMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-25
Report sent to call center — 3 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-01
-
2021-07-21
Call successfulParticipant prefers to complete VAERS report online
-
2021-09-26
Survey response — 6 months, dose 2MedDRA: Breakthrough COVID-19, SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: I had a breakthrough case of COVID-19 and tested positive on 8/24/2021.MedDRA releases: 2024-11 · check-in free text available
-
2021-09-26
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2021-09-28
- 2022-03-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-05 | Pfizer-BioNTech | |
| 2 | 2021-03-26 | Pfizer-BioNTech |
Call center
2 call center cases
1 successful · 1 unsuccessful
Free text
Release 5 — day 0, dose 1
Systemic reaction (other): No
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): None
Systemic reaction (other): No
Systemic reaction (other): No
Systemic reaction (other): No
Release 5 — day 14, dose 1
Symptoms: Having some shortness of breath that may be related to allergies. Daily activities are about the same; may be a little sluggish from the OTC medication.
Release 7 — day 21, dose 2
Symptoms: Yes, Ive had welts on my neck and back this week and the previous week. They are not bothersome unless I wear clothing that rubs the areas. Ill keep watch on these areas to determine if I will seek medical attention.
Release 9 — 3 months, dose 2
Symptoms: Ive suddenly developed gout in my foot. I have no family history and eat a fairly balanced diet.
Healthcare visit (other): Office visit
Release 9 — 6 months, dose 2
Symptoms: I had a breakthrough case of COVID-19 and tested positive on 8/24/2021.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Breakthrough COVID-19 | · | · | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Gout | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Skin irritation | ✓ | ✓ | ✓ |
| SD | Sluggishness | ✓ | ✓ | ✓ |
| SD | Urticaria | ✓ | ✓ | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release